1
Clinical Trials associated with YHP2508C / Not yet recruitingPhase 1 An Open-label, Randomized, Fasting, Single-dose, Oral Administration, 2-sequence, 4-period, Replicate Crossover Study to Evaluate Bioequivalence Between YHP2508C and YHR2603 in Healthy Subjects
An open-label, randomized, fasting, single-dose, oral administration, 2-sequence, 4-period, replicate crossover study to evaluate bioequivalence between YHP2508C and YHR2603 in healthy subjects
100 Clinical Results associated with YHP2508C
100 Translational Medicine associated with YHP2508C
100 Patents (Medical) associated with YHP2508C
100 Deals associated with YHP2508C